|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/343 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61P 25/20 | (2006.01) | ||
| A61K 31/00 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/343 | (2013.01) | ||
| A61K 31/00 | (2006.01) | ||
| A61P 25/20 | (2018.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Number of the document | 3188727 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15766274.3 |
| Date of filing the European patent application | 2015-08-29 | |
| (97) | Date of publication of the European application | 2017-07-12 |
| (45) | Date of publication and mention of the grant of the patent | 2022-11-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/047610 |
| Date | 2015-08-29 |
| (87) | Number | WO 2016/036619 |
| Date | 2016-03-10 |
| (30) | Number | Date | Country code |
| 201462044856 P | 2014-09-02 | US | |
| 201562169635 P | 2015-06-02 | US |
| (72) |
LAVEDAN, Christian , US
POLYMEROPOULOS, Mihael, H. , US
|
| (73) |
Vanda Pharmaceuticals Inc. ,
2200 Pennsylvania Ave NW
Suite 300-E, Washington, DC 20037,
US
|
| (54) | TASIMELTEON FOR TREATING SMITH-MAGENIS SYNDROME |
| TASIMELTEON FOR TREATING SMITH-MAGENIS SYNDROME |